KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to -$37.8 million.

  • Opko Health's Free Cash Flow rose 5555.9% to -$37.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$212.1 million, marking a year-over-year decrease of 603.12%. This contributed to the annual value of -$208.5 million for FY2024, which is 36883.21% down from last year.
  • Opko Health's Free Cash Flow amounted to -$37.8 million in Q3 2025, which was up 5555.9% from -$86.7 million recorded in Q2 2025.
  • Opko Health's Free Cash Flow's 5-year high stood at $28.9 million during Q3 2023, with a 5-year trough of -$86.7 million in Q2 2025.
  • For the 5-year period, Opko Health's Free Cash Flow averaged around -$27.8 million, with its median value being -$33.7 million (2024).
  • Its Free Cash Flow has fluctuated over the past 5 years, first surged by 17254.07% in 2023, then plummeted by 42762.62% in 2024.
  • Over the past 5 years, Opko Health's Free Cash Flow (Quarter) stood at -$12.4 million in 2021, then plummeted by 206.76% to -$38.0 million in 2022, then decreased by 8.85% to -$41.3 million in 2023, then decreased by 20.59% to -$49.8 million in 2024, then increased by 24.17% to -$37.8 million in 2025.
  • Its Free Cash Flow stands at -$37.8 million for Q3 2025, versus -$86.7 million for Q2 2025 and -$37.7 million for Q1 2025.